SUSMED,Inc. Statistics
Total Valuation
SUSMED,Inc. has a market cap or net worth of JPY 4.14 billion. The enterprise value is 183.97 million.
Important Dates
The last earnings date was Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SUSMED,Inc. has 16.81 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 16.81M |
| Shares Outstanding | 16.81M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 42.95% |
| Owned by Institutions (%) | 10.52% |
| Float | 7.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.19 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.52, with zero debt.
| Current Ratio | 19.52 |
| Quick Ratio | 19.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -11.43% and return on invested capital (ROIC) is -3.98%.
| Return on Equity (ROE) | -11.43% |
| Return on Assets (ROA) | -3.78% |
| Return on Invested Capital (ROIC) | -3.98% |
| Return on Capital Employed (ROCE) | -6.50% |
| Weighted Average Cost of Capital (WACC) | 10.68% |
| Revenue Per Employee | 13.58M |
| Profits Per Employee | -9.30M |
| Employee Count | 50 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SUSMED,Inc. has paid 3.00 million in taxes.
| Income Tax | 3.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.86% in the last 52 weeks. The beta is 1.17, so SUSMED,Inc.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -72.86% |
| 50-Day Moving Average | 370.46 |
| 200-Day Moving Average | 718.99 |
| Relative Strength Index (RSI) | 15.86 |
| Average Volume (20 Days) | 162,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SUSMED,Inc. had revenue of JPY 679.00 million and -465.00 million in losses. Loss per share was -27.58.
| Revenue | 679.00M |
| Gross Profit | 658.00M |
| Operating Income | -259.00M |
| Pretax Income | -462.00M |
| Net Income | -465.00M |
| EBITDA | -248.25M |
| EBIT | -259.00M |
| Loss Per Share | -27.58 |
Full Income Statement Balance Sheet
The company has 3.95 billion in cash and no debt, with a net cash position of 3.95 billion or 235.06 per share.
| Cash & Cash Equivalents | 3.95B |
| Total Debt | n/a |
| Net Cash | 3.95B |
| Net Cash Per Share | 235.06 |
| Equity (Book Value) | 3.89B |
| Book Value Per Share | 230.40 |
| Working Capital | 3.82B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -474.00 million and capital expenditures -74.00 million, giving a free cash flow of -548.00 million.
| Operating Cash Flow | -474.00M |
| Capital Expenditures | -74.00M |
| Depreciation & Amortization | 10.75M |
| Net Borrowing | n/a |
| Free Cash Flow | -548.00M |
| FCF Per Share | -32.59 |
Full Cash Flow Statement Margins
Gross margin is 96.91%, with operating and profit margins of -38.14% and -68.48%.
| Gross Margin | 96.91% |
| Operating Margin | -38.14% |
| Pretax Margin | -68.04% |
| Profit Margin | -68.48% |
| EBITDA Margin | -36.56% |
| EBIT Margin | -38.14% |
| FCF Margin | n/a |
Dividends & Yields
SUSMED,Inc. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.32% |
| Shareholder Yield | -0.32% |
| Earnings Yield | -11.21% |
| FCF Yield | -13.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUSMED,Inc. has an Altman Z-Score of 27.99 and a Piotroski F-Score of 1.
| Altman Z-Score | 27.99 |
| Piotroski F-Score | 1 |